4.7 Review

The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

FVIII regulates the molecular profile of endothelial cells: functional impact on the blood barrier and macrophage behavior

Marie Cade et al.

Summary: This study discovered that recombinant human FVIII has direct biological activities on endothelial cells, including decreased cell adhesion, regulation of transcriptomic and protein profiles, increased vascular permeability, and enhanced monocyte adhesion. The findings highlight new functions of FVIII in regulating vascular permeability and leukocyte adhesion and migration.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Review Cell Biology

Mechanisms of SARS-CoV-2 entry into cells

Cody B. Jackson et al.

Summary: The entry of SARS-CoV-2 into host cells is facilitated by the interaction between the viral spike protein and ACE2, leading to virus-cell membrane fusion, which has been extensively studied at the structural and cellular levels worldwide. This understanding has paved the way for the development of effective vaccines in response to the COVID-19 pandemic, caused by the infection with SARS-CoV-2.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)

Review Pediatrics

Developmental hemostasis in the neonatal period

Vicente Rey Y. Formoso et al.

Summary: The hemostatic system undergoes different developmental changes in neonates, leading to differences in the coagulation system compared to other age groups. However, a balance is maintained for physiological hemostasis. Understanding developmental hemostasis is crucial for the care of newborns and children.

WORLD JOURNAL OF PEDIATRICS (2022)

Article Medicine, General & Internal

Acquired coagulation dysfunction resulting from vitamin K-dependent coagulation factor deficiency associated with rheumatoid arthritis: A case report

Yan-Jing Huang et al.

Summary: Rheumatoid arthritis can lead to acquired coagulation dysfunction due to vitamin K-dependent coagulation factor deficiency. Vitamin K1 supplementation has a significant effect on coagulation dysfunction in these cases.

WORLD JOURNAL OF CLINICAL CASES (2022)

Article Hematology

An engineered activated factor V for the prevention and treatment of acute traumatic coagulopathy and bleeding in mice

Bilgimol Chumappumkal Joseph et al.

Summary: (super)FVa can prevent ATC and traumatic bleeding when administered prophylactically, and can stabilize bleeding and reverse abnormal hemostasis parameters when administered while ATC is in progress.

BLOOD ADVANCES (2022)

Review Cell Biology

Endothelial cells and coagulation

Katharina Neubauer et al.

Summary: Endothelial cells play a crucial role in maintaining blood fluidity and controlled vascular hemostasis, balancing procoagulant and anticoagulant mechanisms. They prevent platelet activation and promote fibrinolytic and antithrombotic properties, while also supporting clot formation at sites of vascular damage.

CELL AND TISSUE RESEARCH (2022)

Review Cell Biology

Contribution of proteases to the hallmarks of aging and to age-related neurodegeneration

Mamta Rai et al.

Summary: Protein quality control is crucial for cellular homeostasis and health, with proteases playing a key role in this process. Proteases impact aging and age-related neurodegeneration by regulating various cellular functions and pathogenic protein degradation or generation.

AGING CELL (2022)

Article Biochemistry & Molecular Biology

A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants

Shangjiu Hu et al.

Summary: A new class of HIV-1 protease inhibitors with phenol derived P2 ligands and nitro or halogens in P2' ligands have been designed and synthesized. Compound 17d displays potent enzyme inhibitory activity and greater antiviral activity against the DRV-resistant variant than the wild type virus.

BIOORGANIC & MEDICINAL CHEMISTRY (2022)

Review Hematology

The role of thrombin in haemostasis

Osama M. Al-Amer

Summary: Thrombin plays a central role in coagulation, functioning both as a procoagulant and an anticoagulant, as well as having inflammatory and cellular proliferation effects.

BLOOD COAGULATION & FIBRINOLYSIS (2022)

Review Pharmacology & Pharmacy

Exploiting protease activation for therapy

Chloe Bleuez et al.

Summary: This article provides an overview of therapeutic approaches based on protease activation and highlights recent insights into the spatial and temporal control of proteolytic activation. Two emerging areas of research are covered: antibody therapies targeting the proteolytic activation process of protein precursors and the use of engineered biopharmaceuticals with proteolytically activable pro-forms to increase specificity and improve therapeutic effectiveness.

DRUG DISCOVERY TODAY (2022)

Article Hematology

Therapeutic and technological advancements in haemophilia care: Quantum leaps forward

Magdalena Lewandowska et al.

Summary: The advancements in technological innovations for haemophilia treatment have brought about significant improvements in the quality of life for patients with haemophilia. The emergence of gene therapy, digital applications, and personalized medicine have revolutionized the treatment and care for individuals with haemophilia.

HAEMOPHILIA (2022)

Article Hematology

Low dose prophylaxis and antifibrinolytics: Options to consider with proven benefits for persons with haemophilia

Manuel Carcao et al.

Summary: The use of Lower dose/Lower frequency prophylaxis (LDP) along with increased use of antifibrinolytics offers a cost-effective option for managing patients with severe phenotype haemophilia. LDP results in significant reduction in bleeds, hospital admissions, and days lost from school compared to on demand therapy. Antifibrinolytics can serve as effective adjunctive agents for bleed management and hemostasis for surgeries, potentially reducing the need for expensive factor concentrates.

HAEMOPHILIA (2022)

Article Hematology

Emicizumab state-of-the-art update

Johnny Mahlangu et al.

Summary: Emicizumab, a bispecific monoclonal antibody, has been widely used in the management of patients with haemophilia A with inhibitors. The global rollout of emicizumab has been successful, with diverse dosing regimens and pharmacokinetic tools contributing to its effectiveness and minimal drug wastage. Pediatric studies have confirmed the safety and efficacy of emicizumab.

HAEMOPHILIA (2022)

Article Biochemistry & Molecular Biology

Disruption of Redox Homeostasis by Alterations in Nitric Oxide Synthase Activity and Tetrahydrobiopterin along with Melanoma Progression

Jaqueline Pereira Moura Soares et al.

Summary: Cutaneous melanoma is the most aggressive type of skin cancer, and it progresses through different stages. Reactive oxygen species modulate oncogenic signaling pathways in all stages of melanoma development. The altered concentration of tetrahydrobiopterin disrupts cellular redox homeostasis and contributes to melanoma progression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Psychology, Biological

A critique on the theory of homeostasis

Laurival A. De Luca Jr

Summary: The objective of this critique is to demonstrate that the theory of internal environment (TIE) does not support the theory of homeostasis (TOH). The authors review the concepts of both theories and conclude that there are logical and empirical shortcomings in the TIE, which reduce the scope of the TOH. They suggest the need for a theory that considers both the similarities and crucial divergences of the two theories in order to explain stability in physiology and behavior.

PHYSIOLOGY & BEHAVIOR (2022)

Review Hematology

Efficacy of parenteral formulations of desmopressin in the treatment of bleeding disorders: A systematic review

Shreyas Sreeraman et al.

Summary: This study investigated the hemostatic efficacy of different parenteral formulations of Desmopressin (DDAVP) and found that both subcutaneous and intravenous administration of DDAVP appeared to have similar hemostatic efficacy. However, the strength of these findings is limited by the small number and lack of comparability in the primary studies.

THROMBOSIS RESEARCH (2022)

Review Endocrinology & Metabolism

Proteostasis and resilience: on the interphase between individual's and intracellular stress

Mei-Li Diaz-Hung et al.

Summary: This article discusses the possible mechanistic link between individuals and cellular stress through the imbalance of protein homeostasis in endoplasmic reticulum at the cellular level.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2022)

Review Hematology

Molecular therapeutics of hemophilia A and B

Jie Gong et al.

Summary: This article reviews the molecular mechanisms and potential therapeutic targets of hemophilia A and B, focusing on the functional role of FVIII in blood coagulation and its related molecular pathways. The existing challenges and possible molecular interventions are discussed. Understanding the detailed protein synthesis and secretory pathways of FVIII is of great importance for discovering new treatment methods.

EXPERT REVIEW OF HEMATOLOGY (2022)

Article Multidisciplinary Sciences

Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19

Hengrui Liu et al.

Summary: The authors have described small molecule inhibitors of the SARS-CoV-2 3CL protease for potential treatment of COVID-19. These inhibitors have shown promising antiviral activity and could serve as valuable tools in controlling the ongoing pandemic.

NATURE COMMUNICATIONS (2022)

Article Cell Biology

Ubiquitination-Proteasome System (UPS) and Autophagy Two Main Protein Degradation Machineries in Response to Cell Stress

Yanan Li et al.

Summary: Cells adapt to environmental stimuli by making changes to combat injury and increase stress tolerance. If the damage is too severe to repair, cells undergo apoptosis to protect the overall population. Protein aggregation can cause serious damage to the cells, but ubiquitin plays a crucial role in clearing these abnormal proteins. Dysregulation of ubiquitin-proteasome system and autophagy can lead to the development of diseases.

CELLS (2022)

Review Medicine, General & Internal

Methods to evaluate vascular function: a crucial approach towards predictive, preventive, and personalised medicine

Cristina M. Sena et al.

Summary: This review summarizes recent advances in measuring endothelial function, including invasive and non-invasive techniques, as well as mechanisms and biomarkers of vascular dysfunction. Early identification of vascular dysfunction through non-invasive or minimally invasive techniques is crucial for predictive diagnostics and targeted prevention.

EPMA JOURNAL (2022)

Review Cardiac & Cardiovascular Systems

Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis

Steven P. Grover et al.

Summary: Appropriate activation of coagulation requires a balance between procoagulant and anticoagulant proteins in blood. SERPIN anticoagulants function by forming irreversible inhibitory complexes with target coagulation proteases. Mutations in SERPIN family members can cause hereditary thrombophilias, and low plasma levels of SERPINs are associated with an increased risk of thrombosis. Engineered SERPINs hold potential as novel therapies for the treatment of thrombotic pathologies.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Review Cardiac & Cardiovascular Systems

Current Knowledge on Factor V Leiden Mutation as a Risk Factor for Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis

Daria Eppenberger et al.

Summary: This study aimed to summarize and evaluate the association between heterozygous FVL mutation and recurrent VTE. The study found that heterozygous FVL mutation increased the risk of recurrent VTE, but its impact was marginal in the presence of other known risk factors.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Article Hematology

How I treat immune-mediated thrombotic thrombocytopenic purpura after hospital discharge

Frank Akwaa et al.

Summary: This article reviews the main risk factors for relapse, exacerbation, and long-term complications of immune-mediated thrombocytopenic purpura (iTTP), as well as discusses the approach to observing patients with iTTP and providing long-term follow-up in the outpatient setting.

BLOOD (2022)

Article Nursing

Factor V Leiden Development of VTE in Surgery and Trauma Patients: A Systematic Review

Morgan Morrow et al.

Summary: Factor V Leiden (FVL) is a hereditary thrombophilia that increases the risk of venous thromboembolism (VTE) in patients after surgery and trauma. However, the management of VTE is no different for individuals with FVL compared with those without FVL.

DIMENSIONS OF CRITICAL CARE NURSING (2022)

Review Biochemistry & Molecular Biology

Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature's toolbox of bioactive compounds

Io Antonopoulou et al.

Summary: The emergence of SARS-CoV-2 has led to a long pandemic with significant global impact. Developing inhibitors against the main protease offers promising solutions to combat the virus and potential mutations.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)

Article Medicine, General & Internal

The Effect of Switching From Warfarin to Novel Oral Anticoagulants on Patients' Satisfaction and the Travel Burden in a Rural Setting

Samir Khiralla et al.

Summary: The switch from warfarin to NOACs has been shown to significantly reduce travel burden, increase treatment satisfaction, and adherence for patients, especially those living in remote areas. This conversion has improved the quality of life for these patients.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Review Biochemistry & Molecular Biology

Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature's toolbox of bioactive compounds

Io Antonopoulou et al.

Summary: The emergence of SARS-CoV-2 has resulted in a global pandemic, and it is crucial to develop further methods to combat the infection and inhibit viral mutations. The main protease (Mpro) of the virus is an attractive target for inhibitors development. This article aims to present the research results of Mpro inhibitors to date and provide a basis for effective solutions against SARS-CoV-2 and future outbreaks. Evaluating the functionality of these compounds in in vitro and in vivo assays.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)

Article Hematology

Impact of novel hemophilia therapies around the world

Margareth C. Ozelo et al.

Summary: The field of hemophilia care has seen a revolution with the development of nonfactor therapy and gene therapy. Nonreplacement agents and gene therapy have shown promising results and novel treatment approaches are being researched. The World Federation of Hemophilia Humanitarian Aid Program is working towards increasing access to these new therapies in resource-constrained countries. However, ensuring treatment for all remains a major challenge.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)

Review Cardiac & Cardiovascular Systems

Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardioloy working Groups on Artherosclerosis and Vascular Biology, Aorta and Perirpheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and Thrombosis

Yvonne Alexander et al.

Summary: Endothelial cells play a crucial role in cardiovascular health, and dysfunction can be caused by cardiovascular risk factors but restored once stimuli are removed. There are various methods to measure endothelial function, with each having its pros and cons. It is recommended to adopt a consensus methodology like flow-mediated dilatation and establish reference values for different populations. Future studies should explore the integration of endothelial function measurements with patient-specific epigenetic data and other biomarkers.

CARDIOVASCULAR RESEARCH (2021)

Article Hematology

Tissue factor pathway inhibitor is required for cerebrovascular development in mice

Susan A. Maroney et al.

Summary: TFPI and FV play crucial roles in regulating hemostasis and vascular development during embryogenesis. The activity of TFPI within the CNS has been identified to modulate cerebral vascular development by dampening FV-dependent procoagulant activity.

BLOOD (2021)

Review Hematology

Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies

Takayuki Ikezoe

Summary: Haematological malignancies can cause DIC, with concomitant poor prognosis. The Japanese Society on Thrombosis and Hemostasis has released new DIC diagnostic criteria and recombinant human soluble thrombomodulin is commonly used for treatment. Innovative therapies like HSCT and CAR-T-cell therapy can cure some patients with haematological malignancies, but may lead to coagulopathy.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2021)

Article Hematology

Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies

Michael U. Callaghan et al.

Summary: Long-term data from pooled studies show that prophylaxis with emicizumab maintains low bleed rates in persons with hemophilia A of all ages, with good tolerability and no new safety concerns.

BLOOD (2021)

Review Hematology

Von Willebrand disease type 2N: An update

Omid Seidizadeh et al.

Summary: Von Willebrand disease is caused by quantitative or qualitative defects of von Willebrand factor (VWF). Type 2N VWD is a rare recessive disorder that requires accurate diagnosis and differentiation from other bleeding disorders such as mild/moderate hemophilia A.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Article Hematology

Type 2B von Willebrand Disease: Early Manifestation as Neonatal Thrombocytopenia

David Kranzhoefer et al.

Summary: This report presents a case of a preterm female newborn with VWD 2B, diagnosed through molecular genetic analysis and blood tests, and successfully treated with VWF-containing plasma concentrate. The patient was discharged at the age of 2 months with stabilized platelet count and no bleeding signs.

HAMOSTASEOLOGIE (2021)

Article Hematology

ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease

Paula D. James et al.

Summary: These evidence-based guidelines on von Willebrand disease (VWD) provide 11 key recommendations for clinicians and patients, covering various aspects of VWD diagnosis, including the use of bleeding-assessment tools, diagnostic assays, laboratory cutoffs, and genetic testing versus phenotypic assays. Future critical research priorities are also identified.

BLOOD ADVANCES (2021)

Article Hematology

ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease

Nathan T. Connell et al.

Summary: These evidence-based guidelines from ASH, ISTH, NHF, and WFH are intended to support patients, clinicians, and health care professionals in their decisions about management of VWD. The panel agreed on 12 recommendations and outlined future research priorities.

BLOOD ADVANCES (2021)

Article Hematology

Cryo-EM structures of human coagulation factors V and Va

Eliza A. Ruben et al.

Summary: The cryo-EM structures of human coagulation factors V and Va reveal their assembly and function mechanisms, offering a molecular understanding of the clotting process.

BLOOD (2021)

Review Medicine, General & Internal

Alzheimer's disease

Philip Scheltens et al.

Summary: Alzheimer's disease is projected to see a significant increase in prevalence in the future, with genetics playing a key role. Novel biomarkers and lifestyle-based prevention trials show promising therapeutic potential. Promising pharmacological treatments are advancing in clinical trials, targeting amyloid beta, tau, and inflammation.

LANCET (2021)

Review Medicine, General & Internal

Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management

Senthil Sukumar et al.

Summary: TTP is a rare but dangerous disorder characterized by hemolysis, thrombocytopenia, and ischemic damage, often caused by ADAMTS13 deficiency. Front-line treatment typically involves plasma exchange and immunosuppression, as well as drugs like rituximab and caplacizumab. Refractory cases may require alternative therapies.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Hematology

Plasminogen: an enigmatic zymogen

Charithani B. Keragala et al.

Summary: Plasminogen and plasmin play important roles not only in fibrinolysis but also in various physiological processes such as wound repair and modulation of cell behavior. The use of antifibrinolytic agents to reduce bleeding may have additional clinically relevant consequences, particularly in reducing infection risk. The broadening role of the plasminogen-activating system in physiology and pathophysiology suggests that manipulation of this system may have benefits unrelated to its conventional application in thrombosis and hemostasis.

BLOOD (2021)

Review Pharmacology & Pharmacy

Haemophilia, state of the art and new therapeutic opportunities, a regulatory perspective

Francesca Tomeo et al.

Summary: Haemophilia A and B, rare bleeding disorders, have transformed into manageable conditions in the Western world, but challenges remain, and new therapeutic opportunities including gene therapy show promise for a definite clinical cure.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Article Cell Biology

Proteasome stress in skeletal muscle mounts a long-range protective response that delays retinal and brain aging

Mamta Rai et al.

Summary: The moderate disruption of proteasome in skeletal muscle induces a signaling mechanism involving amylase and maltose, which reduces the accumulation of poly-ubiquitinated proteins in the aging brain and retina. This adaptive response helps maintain proteostasis and neuronal activity in the aging brain by hindering neurodegeneration.

CELL METABOLISM (2021)

Review Biotechnology & Applied Microbiology

Current and Future Options of Haemophilia A Treatments

Wolfgang Miesbach et al.

Summary: New treatment options for hemophilia A, including innovative factor concentrates and non-factor products with extended half-life, are expected to significantly benefit patients, improve bleeding protection and quality of life. The development of treatment algorithms and the potential challenge to traditional therapies by new treatments remain uncertain.

EXPERT OPINION ON BIOLOGICAL THERAPY (2021)

Review Cell Biology

Weibel Palade Bodies: Unique Secretory Organelles of Endothelial Cells that Control Blood Vessel Homeostasis

Johannes Nass et al.

Summary: Vascular endothelial cells play a crucial role in regulating vascular functions and interactions with blood cells to ensure smooth blood flow and specific responses to vascular injury and inflammation. These cells have the ability to rapidly change their surface properties to control blood flow effectively.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Medicine, General & Internal

Parkinson's disease

Bastiaan R. Bloem et al.

Summary: Parkinson's disease is a neurodegenerative condition with diverse causes and clinical presentations. Diagnosis is clinically based, and treatment goals vary from person to person, emphasizing the need for personalized management. Currently, there is no therapy to slow down or arrest the progression of Parkinson's disease.

LANCET (2021)

Review Cell Biology

Systemic manifestation and contribution of peripheral tissues to Huntington's disease pathogenesis

Chia-Lung Chuang et al.

Summary: Huntington disease is a neurodegenerative disorder caused by a genetic mutation, affecting both the central nervous system and peripheral tissues. Systemic signaling from peripheral tissues can influence the progression of the disease in the brain, showcasing the interconnected nature of Huntington disease pathogenesis.

AGEING RESEARCH REVIEWS (2021)

Article Oncology

Rare Coagulation Factor Deficiencies (Factors VII, X, V, and II)

Glaivy Batsuli et al.

Summary: Inherited bleeding disorders like RBD, although rare, can have a significant impact on quality of life and require careful clinical management. Factor replacement remains the primary treatment, with adjuvant therapies such as antifibrinolytics playing a crucial role in managing bleeding symptoms. Further research on alternative treatments and prophylaxis guidelines is needed to improve care for individuals with RBD.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)

Review Biochemistry & Molecular Biology

Gene Therapy in Hemophilia: Recent Advances

E. Carlos Rodriguez-Merchan et al.

Summary: Hemophilia is a monogenic mutational disease affecting coagulation factor genes, with recombinant clotting factors being the current preferred treatment. Advanced gene therapies show promise for a curative effect, but are associated with immunogenicity and hepatotoxicity that need to be optimized. It is important for both physicians and patients to understand the potential benefits and risks of new therapies, and to maintain a registry of gene therapy patients to track efficacy and long-term adverse events.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Emerging Approaches to Understanding Microvascular Endothelial Heterogeneity: A Roadmap for Developing Anti-Inflammatory Therapeutics

Qingliang Yang et al.

Summary: The endothelium, the inner layer of blood vessels, plays a crucial role in hemostasis and regulation of systemic inflammatory response. However, there are concerns about the phenotypic heterogeneity of microvascular endothelial cells between different organs and species, which may pose challenges in developing therapeutics targeting endothelium inflammation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Hematology

Vascular abnormalities in patients with von Willebrand disease: A scoping review

Nicholas L. J. Chornenki et al.

Summary: Vascular abnormalities in patients with VWD primarily occur in the gastrointestinal tract, with type 2A and type 3 VWD being the most common subtypes affected. The clinical treatment and natural history of these abnormalities remain understudied, highlighting the need for further research.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Article Medicine, Research & Experimental

Regulation of endothelial cell differentiation in embryonic vascular development and its therapeutic potential in cardiovascular diseases

Zi Guo et al.

Summary: During vertebrate development, the cardiovascular system becomes functional earlier than other organs. Endothelial cells play a crucial role in vasculogenesis and angiogenesis, with cellular biology and epigenetics being important factors in these processes. There is growing interest in the role of proteins and signaling molecules in controlling embryonic vascular development, and the transplantation of iPSC-ECs shows promise in treating cardiovascular diseases. However, challenges in maintaining cell viability and function limit the clinical application of iPSC-ECs in regenerative medicine.

LIFE SCIENCES (2021)

Article Peripheral Vascular Disease

Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19)

Amir Hossein Norooznezhad et al.

Summary: COVID-19 disease involves not only cytokine storm, but also endothelial cell dysfunction and pathologic angiogenesis. These pathological processes may interact with each other through different pathways, and a comprehensive approach is needed in treatment.

MICROVASCULAR RESEARCH (2021)

Article Hematology

Type 2A and 2M von Willebrand Disease: Differences in Phenotypic Parameters According to the Affected Domain by Disease-Causing Variants and Assessment of Pathophysiological Mechanisms

Adriana Ines Woods et al.

Summary: Type 2A and 2M von Willebrand disease (VWD) have similar phenotypic parameters but involve different pathophysiological mechanisms. The absence of large and intermediate von Willebrand factor (VWF) multimers in 2A may contribute to higher bleeding scores and major bleeding episodes. Disease-causing variants (DCVs) clustered in the VWF-A1 domain of type 2A resulted in more severe clinical profiles, while DCVs in the VWF-A2 domain of type 2M showed patterns mainly related to shortened survival. High levels of major bleeding in 2M patients with DCV in the VWF-A2 domain may be due to abnormal C1B/Ag and reduced VWF-GPIb binding.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2021)

Article Multidisciplinary Sciences

Characterization and visualization of murine coagulation factor VIII-producing cells in vivo

Morisada Hayakawa et al.

Summary: The study found that in mice, FVIII is produced only from liver sinusoidal endothelial cells exhibiting high levels of CD31, CD146, Lyve1, CLEC-2, and negative for podoplanin expression.

SCIENTIFIC REPORTS (2021)

Article Medicine, General & Internal

Haemophilia

Erik Berntorp et al.

Summary: Haemophilia A and B are rare congenital disorders caused by deficiency of clotting factors, leading to symptoms such as bleeding and joint disease. With advancements in treatment, individuals with haemophilia can now expect almost normal life expectancy and quality of life, although the development of inhibitory antibodies remains a major challenge for some patients. Gene therapy for haemophilia is progressing and may soon become a reality.

NATURE REVIEWS DISEASE PRIMERS (2021)

Article Cell Biology

Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A

Christopher Stem et al.

Summary: Patients with severe hemophilia A can face life-threatening bleeding, and current FVIII replacement therapy has limitations in terms of duration and availability. By evaluating different cell types as potential vehicles for delivering F8 gene transduction, promising candidates for long-lasting FVIII replacement have been identified.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Biochemistry & Molecular Biology

Inflammatory Mechanisms Contributing to Endothelial Dysfunction

Panagiotis Theofilis et al.

Summary: Maintenance of endothelial cell integrity is crucial for human health, as dysfunction can lead to various diseases. Activated and injured endothelial cells release inflammatory mediators and enter a pro-thrombotic state, ultimately promoting atherosclerosis progression. Various pathways and mechanisms contribute to endothelial dysfunction, highlighting the complexity of this process.

BIOMEDICINES (2021)

Article Hematology

Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS-13 activity and autoantibodies

Francesca Palandri et al.

Summary: This study reports three cases of ITTP during the COVID-19 pandemic that received systematic evaluation of ADAMTS-13 activity and autoantibodies. The introduction of caplacizumab and ADAMTS-13 monitoring may change the management of ITTP patients, with therapy guided by ADAMTS-13 activity kinetics rather than clinical remission. Prospective evaluation of ADAMTS-13 and use of updated IWG definitions may improve real-life patient management in the caplacizumab era.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2021)

Review Toxicology

Development challenges associated with rAAV-based gene therapies

Michael W. Bolt et al.

Summary: Gene therapies are a novel method to potentially cure many diseases, with gene suppression or editing possible. Adeno-associated viruses are commonly used to deliver these therapies but come with manufacturing and clinical challenges. Regulatory expectations are evolving, with nonclinical toxicities such as immunogenicity and neurotoxicity being observed, influencing the regulatory studies required for clinical trials and marketing authorizations.

JOURNAL OF TOXICOLOGICAL SCIENCES (2021)

Review Pharmacology & Pharmacy

Direct Oral Anticoagulants in Select Patients With Hypercoagulable Disorders

Sara M. Valanejad et al.

Summary: The study summarizes the safety and efficacy of DOACs in acute treatment and secondary prevention of venous thromboembolism in patients with hypercoagulable disorders. Data suggests that for cancer-associated thrombosis, edoxaban, rivaroxaban, and apixaban are preferred options, with apixaban having lower bleeding rates. However, the use of DOACs in antiphospholipid syndrome and hereditary thrombophilia patients should currently be avoided.

ANNALS OF PHARMACOTHERAPY (2021)

Article Cardiac & Cardiovascular Systems

Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients

Paola Canzano et al.

Summary: The authors suggest that the cytokine storm in COVID-19 patients can lead to sustained cell-based activation of coagulation and altered platelet activity, which can be intervened through prophylactic anticoagulant treatment.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)

Article Biochemistry & Molecular Biology

Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database

Stephanie Nguengang Wakap et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2020)

Review Medical Laboratory Technology

Activated protein C assays: A review

Julia Oto et al.

CLINICA CHIMICA ACTA (2020)

Article Hematology

Hemophilia A in Females: Considerations for Clinical Management

Paulette Bryant et al.

ACTA HAEMATOLOGICA (2020)

Article Cardiac & Cardiovascular Systems

Inflammation and atherosclerosis: what is on the horizon?

Neil Ruparelia et al.

HEART (2020)

Review Biochemistry & Molecular Biology

Genetically Engineered Pigs to Study Cancer

Daniela Kalla et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biotechnology & Applied Microbiology

AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer

Helena Costa Verdera et al.

MOLECULAR THERAPY (2020)

Review Biotechnology & Applied Microbiology

Therapies for rare diseases: therapeutic modalities, progress and challenges ahead

Erik Tambuyzer et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Editorial Material Multidisciplinary Sciences

Translating preclinical models to humans

Douglas K. Brubaker et al.

SCIENCE (2020)

Review Medicine, Research & Experimental

Sepsis therapies: learning from 30 years of failure of translational research to propose new leads

Jean-Marc Cavaillon et al.

EMBO MOLECULAR MEDICINE (2020)

Review Pharmacology & Pharmacy

Targeting drug delivery in the vascular system: Focus on endothelium

Patrick M. Glassman et al.

ADVANCED DRUG DELIVERY REVIEWS (2020)

Review Hematology

Anticoagulant and signaling functions of antithrombin

Alireza R. Rezaie et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Review Hematology

How I treat von Willebrand disease

Giancarlo Castaman

THROMBOSIS RESEARCH (2020)

Review Medicine, General & Internal

ADMA: A Key Player in the Relationship between Vascular Dysfunction and Inflammation in Atherosclerosis

Laura Dowsett et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Review Medicine, General & Internal

Protein C Deficiency as a Risk Factor for Stroke in Young Adults: A Review

Zainab Majid et al.

CUREUS JOURNAL OF MEDICAL SCIENCE (2020)

Review Medicine, Research & Experimental

Entering the Modern Era of Gene Therapy

Xavier M. Anguela et al.

ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)

Article Hematology

Intrinsic Pathway of Coagulation and Thrombosis: Insights From Animal Models

Steven P. Grover et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)

Review Biochemistry & Molecular Biology

Humanized mouse models of immunological diseases and precision medicine

Leonard D. Shultz et al.

MAMMALIAN GENOME (2019)

Article Cell Biology

Domain-specific mechanical modulation of VWF-ADAMTS13 interaction

Zhenhai Li et al.

MOLECULAR BIOLOGY OF THE CELL (2019)

Article Hematology

A Comprehensive Overview of Coagulation Factor V and Congenital Factor V Deficiency

Shadi Tabibian et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)

Article Hematology

Mechanisms of vascular permeability and remodeling associated with hemarthrosis in factor VIII-deficient mice

Esther J. Cooke et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)

Article Multidisciplinary Sciences

Laboratory mice born to wild mice have natural microbiota and model human immune responses

Stephan P. Rosshart et al.

SCIENCE (2019)

Review Hematology

Clinical Application of Thromboelastography/Thromboelastometry (TEG/TEM) in the Neonatal Population: A Narrative Review

Aikaterini Konstantinidi et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)

Review Hematology

How I manage severe von Willebrand disease

Frank W. G. Leebeek et al.

BRITISH JOURNAL OF HAEMATOLOGY (2019)

Review Cardiac & Cardiovascular Systems

Endothelial Cell Development and Its Application to Regenerative Medicine

Jingyao Qiu et al.

CIRCULATION RESEARCH (2019)

Review Hematology

The role of genetics in the pathogenesis and diagnosis of type 1 Von Willebrand disease

Veronica H. Flood et al.

CURRENT OPINION IN HEMATOLOGY (2019)

Article Hematology

Hemophilia A and B: molecular and clinical similarities and differences

Giancarlo Castaman et al.

HAEMATOLOGICA (2019)

Review Biochemistry & Molecular Biology

Vascular Endothelial Cell Biology: An Update

Anne Krueger-Genge et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Hematology

The evolution of recombinant factor replacement for hemophilia

Amanda D. Sankar et al.

TRANSFUSION AND APHERESIS SCIENCE (2019)

Review Medicine, General & Internal

Treatment Options in Hemophilia

Wolfgang Miesbach et al.

DEUTSCHES ARZTEBLATT INTERNATIONAL (2019)

Review Hematology

Treatment of rare factor deficiencies other than hemophilia

Marzia Menegatti et al.

BLOOD (2019)

Article Cell & Tissue Engineering

Endothelial Stem and Progenitor Cells for Regenerative Medicine

Kimihiko Banno et al.

CURRENT STEM CELL REPORTS (2019)

Article Cardiac & Cardiovascular Systems

Von Willebrand factor revisited

Senan J. Yasar et al.

JOURNAL OF INTERVENTIONAL CARDIOLOGY (2018)

Review Hematology

Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis

Steven P. Grover et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)

Article Cell & Tissue Engineering

CD157 Marks Tissue-Resident Endothelial Stem Cells with Homeostatic and Regenerative Properties

Taku Wakabayashi et al.

CELL STEM CELL (2018)

Review Pharmacology & Pharmacy

Rare genetic diseases: update on diagnosis, treatment and online resources

Robert E. Pogue et al.

DRUG DISCOVERY TODAY (2018)

Review Biochemistry & Molecular Biology

Regulation of von-Willebrand Factor Secretion from Endothelial Cells by the Annexin A2-S100A10 Complex

Anna Holthenrich et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Multidisciplinary Sciences

Identification of serpins specific for activated protein C using a lysate-based screening assay

Stephanie G. I. Polderdijk et al.

SCIENTIFIC REPORTS (2018)

Article Hematology

Management of rare coagulation disorders in 2018

Shilpa Jain et al.

TRANSFUSION AND APHERESIS SCIENCE (2018)

Article Multidisciplinary Sciences

Human Organ-Specific Endothelial Cell Heterogeneity

Raluca Marcu et al.

ISCIENCE (2018)

Article Hematology

Lifecycle of Weibel-Palade bodies

Marjon Mourik et al.

HAMOSTASEOLOGIE (2017)

Article Oncology

Evaluation and Management of Congenital Bleeding Disorders

Rahul Bhat et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2017)

Article Nanoscience & Nanotechnology

Targeted multidrug delivery system to overcome chemoresistance in breast cancer

Yuan Tang et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)

Article Biochemistry & Molecular Biology

Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation

Salvatore Santamaria et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

Review Hematology

Von Willebrand factor and angiogenesis: basic and applied issues

A. M. Randi et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)

Article Cardiac & Cardiovascular Systems

New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice

A. Girolami et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)

Article Surgery

Platelet-derived factor V promotes angiogenesis in a mouse hind limb ischemia model

Yan Yang et al.

JOURNAL OF VASCULAR SURGERY (2017)

Review Medical Laboratory Technology

Coagulation Testing in the Core Laboratory

William E. Winter et al.

LABORATORY MEDICINE (2017)

Review Cardiac & Cardiovascular Systems

Extracellular vesicles in coronary artery disease

Chantal M. Boulanger et al.

NATURE REVIEWS CARDIOLOGY (2017)

Review Pharmacology & Pharmacy

Distinct characteristics of neonatal platelet reactivity

Belay Tesfamariam

PHARMACOLOGICAL RESEARCH (2017)

Review Hematology

Von Willebrand disease mutation spectrum and associated mutation mechanisms

Annika de Jong et al.

THROMBOSIS RESEARCH (2017)

Review Medical Laboratory Technology

Coagulation Testing in the Core Laboratory

William E. Winter et al.

LABORATORY MEDICINE (2017)

Review Hematology

Acquired hemophilia A: Updated review of evidence and treatment guidance

Rebecca Kruse-Jarres et al.

AMERICAN JOURNAL OF HEMATOLOGY (2017)

Review Hematology

Genetic diagnosis in hemophilia and von Willebrand disease

Laura L. Swystun et al.

BLOOD REVIEWS (2017)

Article Hematology

Factor V Leiden

Elizabeth M. Van Cott et al.

AMERICAN JOURNAL OF HEMATOLOGY (2016)

Review Hematology

Tissue Factor Pathway Inhibitor Multiple Anticoagulant Activities for a Single Protein

Alan E. Mast

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)

Review Biochemistry & Molecular Biology

The factor VIII protein and its function

Anna Mazurkiewicz-Pisarek et al.

ACTA BIOCHIMICA POLONICA (2016)

Article Hematology

Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders

Bjorn Dahlback

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2016)

Review Cell Biology

Endothelial Dysfunction and Inflammation: Immunity in Rheumatoid Arthritis

XueZhi Yang et al.

MEDIATORS OF INFLAMMATION (2016)

Review Medicine, General & Internal

Von Willebrand's Disease

Frank W. G. Leebeek et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Review Pediatrics

The bleeding newborn: A review of presentation, diagnosis, and management

Julie Jaffray et al.

SEMINARS IN FETAL & NEONATAL MEDICINE (2016)

Article Gastroenterology & Hepatology

Coagulopathy and transfusion therapy in pediatric liver transplantation

Mirco Nacoti et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Article Education, Scientific Disciplines

Treatment of rare factor deficiencies in 2016

Flora Peyvandi et al.

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)

Article Hematology

Vascular remodeling underlies rebleeding in hemophilic arthropathy

Vikas Bhat et al.

AMERICAN JOURNAL OF HEMATOLOGY (2015)

Review Hematology

Fibrinolysis and the control of blood coagulation

John C. Chapin et al.

BLOOD REVIEWS (2015)

Article Obstetrics & Gynecology

Congenital and acquired bleeding disorders in infancy

Sally Elizabeth Campbell et al.

EARLY HUMAN DEVELOPMENT (2015)

Editorial Material Hematology

Why and how do we classify von Willebrand disease?

C. Millar

HAEMOPHILIA (2015)

Article Cell Biology

Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism

Felix Jansen et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)

Article Hematology

Coagulation indices in very preterm infants from cord blood and postnatal samples

E. Neary et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)

Review Hematology

Half-life extended factor VIII for the treatment of hemophilia A

A. Tiede

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)

Article Hematology

Bleeding issues in neonates and infants - update 2015

Ulrike Nowak-Goettl et al.

THROMBOSIS RESEARCH (2015)

Review Pharmacology & Pharmacy

Endothelial nanomedicine for the treatment of pulmonary disease

Jacob S. Brenner et al.

EXPERT OPINION ON DRUG DELIVERY (2015)

Article Hematology

Murine coagulation factor VIII is synthesized in endothelial cells

Lesley A. Everett et al.

BLOOD (2014)

Review Hematology

The History and Evolution of the Clinical Effectiveness of Haemophilia Type A Treatment: A Systematic Review

Hector E. Castro et al.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2014)

Article Hematology

Human liver sinusoidal endothelial cells but not hepatocytes contain factor VIII

T. Shahani et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)

Article Nanoscience & Nanotechnology

Targeted delivery of vascular endothelial growth factor improves stem cell therapy in a rat myocardial infarction model

Yuan Tang et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)

Article Multidisciplinary Sciences

An Engineered Factor Va Prevents Bleeding Induced by Anticoagulant wt Activated Protein C

Annette von Drygalski et al.

PLOS ONE (2014)

Review Anesthesiology

Overview of the coagulation system

Sanjeev Palta et al.

INDIAN JOURNAL OF ANAESTHESIA (2014)

Article Medicine, General & Internal

Coagulation

Y. L. Chee

JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH (2014)

Editorial Material Critical Care Medicine

Humanizing the Mouse: In Defense of Murine Models of Critical Illness

Harris Perlman et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Article Hematology

The effect of labour on the coagulation system in the term neonate

A. A. Kulkarni et al.

HAEMOPHILIA (2013)

Review Biochemistry & Molecular Biology

The Vascular Endothelium and Human Diseases

Peramaiyan Rajendran et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2013)

Article Cell Biology

eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases

Annarita Di Lorenzo et al.

JOURNAL OF CELL SCIENCE (2013)

Review Physiology

NEW FUNDAMENTALS IN HEMOSTASIS

Henri H. Versteeg et al.

PHYSIOLOGICAL REVIEWS (2013)

Article Pediatrics

Developmental Hemostasis Clinical Implications From the Fetus to the Adolescent

Julie Jaffray et al.

PEDIATRIC CLINICS OF NORTH AMERICA (2013)

Article Multidisciplinary Sciences

Genomic responses in mouse models poorly mimic human inflammatory diseases

Junhee Seok et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Pediatrics

Neonatal hematology

Jose Diaz-Miron et al.

SEMINARS IN PEDIATRIC SURGERY (2013)

Article Hematology

Combined Deficiency of Coagulation Factors V and VIII: An Update

Chunlei Zheng et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2013)

Article Hematology

Role of the coagulation system in development

Muhammed Kashif et al.

THROMBOSIS RESEARCH (2013)

Article Pediatrics

The preterm infant with thrombosis

Rukhmi Bhat et al.

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2012)

Review Hematology

Elevated factor VIII levels and risk of venous thrombosis

P. Vince Jenkins et al.

BRITISH JOURNAL OF HAEMATOLOGY (2012)

Article Pharmacology & Pharmacy

The Role of Nitric Oxide on Endothelial Function

Dimitris Tousoulis et al.

CURRENT VASCULAR PHARMACOLOGY (2012)

Article Hematology

Endothelial progenitor cell-based therapy for hemophilia A

Hideto Matsui

INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)

Article Hematology

Protein C anticoagulant and cytoprotective pathways

John H. Griffin et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)

Article Cardiac & Cardiovascular Systems

Pentraxin-3 Predicts Functional Recovery and 1-Year Major Adverse Cardiovascular Events After Rehabilitation of Cardiac Surgery Patients

Maurizio Ferratini et al.

JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION (2012)

Article Medicine, Research & Experimental

New insights into the mechanisms of venous thrombosis

Nigel Mackman

JOURNAL OF CLINICAL INVESTIGATION (2012)

Article Obstetrics & Gynecology

The coagulation system of extremely preterm infants: influence of perinatal risk factors on coagulation

C. Poralla et al.

JOURNAL OF PERINATOLOGY (2012)

Article Hematology

Circulating Biomarkers

L. Badimon et al.

THROMBOSIS RESEARCH (2012)

Editorial Material Hematology

Blood Coagulation and Blood Vessel Development Is Tissue Factor the Missing Link?

Nigel Mackman et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)

Article Hematology

Neoangiogenesis contributes to the development of hemophilic synovitis

Suchitra S. l Acharya et al.

BLOOD (2011)

Article Hematology

Endothelial von Willebrand factor regulates angiogenesis

Richard D. Starke et al.

BLOOD (2011)

Article Hematology

Genotyping the factor VIII intron 22 inversion locus using fluorescent in situ hybridization

Campbell R. Sheen et al.

BLOOD CELLS MOLECULES AND DISEASES (2011)

Review Hematology

Platelets at work in primary hemostasis

Katleen Broos et al.

BLOOD REVIEWS (2011)

Review Anesthesiology

Principles of hemostasis in children: models and maturation

Nina A. Guzzetta et al.

PEDIATRIC ANESTHESIA (2011)

Article Pediatrics

Developmental haemostasis: Secondary haemostasis

Paul Monagle et al.

SEMINARS IN FETAL & NEONATAL MEDICINE (2011)

Article Pediatrics

Developmental hemostasis: Primary hemostasis and evaluation of platelet function in neonates

T. Strauss et al.

SEMINARS IN FETAL & NEONATAL MEDICINE (2011)

Article Hematology

The Coagulation System in Children: Developmental and Pathophysiological Considerations

Vera Ignjatovic et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2011)

Review Hematology

Hemostasis in neonates and children: Pitfalls and dilemmas

Paul Monagle et al.

BLOOD REVIEWS (2010)

Review Developmental Biology

Endothelial cell plasticity: how to become and remain a lymphatic endothelial cell

Guillermo Oliver et al.

DEVELOPMENT (2010)

Article Hematology

Activated factor X cleaves factor VIII at arginine 562, limiting its cofactor efficiency

J. L. Plantier et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)

Article Hematology

Health-related quality of life among adult patients with moderate and severe von Willebrand disease

E. M. de Wee et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)

Review Biochemical Research Methods

Macro- and microscale fluid flow systems for endothelial cell biology

Edmond W. K. Young et al.

LAB ON A CHIP (2010)

Article Hematology

Haemostatic profile of healthy premature small for gestational age neonates

George Mitsiakos et al.

THROMBOSIS RESEARCH (2010)

Review Medicine, General & Internal

Diabetes mellitus: new challenges and innovative therapies

Cristina M. Sena et al.

EPMA JOURNAL (2010)

Article Cardiac & Cardiovascular Systems

Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community

Rainer H. Boeger et al.

CIRCULATION (2009)

Article Hematology

Slow thrombin is zymogen-like

J. A. Huntington

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)

Review Oncology

Targeting angiogenesis: progress with anti-VEGF treatment with large molecules

Axel Grothey et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2009)

Article Hematology

Combined Factor V and Factor VIII Deficiency

Marta Spreafico et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2009)

Article Hematology

Factor V Deficiency

Rosanna Asselta et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2009)

Article Hematology

Haemostatic profile of full-term, healthy, small for gestational age neonates

George Mitsiakos et al.

THROMBOSIS RESEARCH (2009)

Article Urology & Nephrology

Coronary artery calcification, ADMA, and insulin resistance in CKD patients

Shuzo Kobayashi et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)

Article Medicine, Research & Experimental

Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice

Antonia Follenzi et al.

JOURNAL OF CLINICAL INVESTIGATION (2008)

Article Hematology

Platelet-derived microparticles and coagulation activation in breast cancer patients

Bettina Toth et al.

THROMBOSIS AND HAEMOSTASIS (2008)

Article Hematology

Different behaviour of soluble CD40L concentrations can be reflected by variations of preanalytical conditions

F. Wenzel et al.

CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2008)

Article Hematology

Coagulation testing in pediatric patients: The young are not just miniature adults

Giuseppe Lipp et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)

Article Cardiac & Cardiovascular Systems

Routine coagulation tests in newborn and young infants

Giuseppe Lippi et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2007)

Article Hematology

Binding of factor Vila to the endothelial cell protein C receptor reduces its coagulant activity

J. Lopez-Sagaseta et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

Article Medicine, Research & Experimental

Study of the mechanism of hemostatic effect of desmopressin

D. M. Zubairov et al.

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2007)

Article Hematology

Activated protein C

J. H. Griffin et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

Article Hematology

In vivo thrombus formation

B. Furie et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

Article Urology & Nephrology

The past, presence and future of ADMA in nephrology

Jan T. Kielstein et al.

NEPHROLOGIE & THERAPEUTIQUE (2007)

Review Cardiac & Cardiovascular Systems

Endothelial function and dysfunction - Testing and clinical relevance

John E. Deanfield et al.

CIRCULATION (2007)

Article Oncology

Coagulation 2006: A modern view of hemostasis

Maureane Hoffman et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)

Review Hematology

Coagulation factorV and thrombophilia: Background and mechanisms

Kenneth Segers et al.

THROMBOSIS AND HAEMOSTASIS (2007)

Article Cardiac & Cardiovascular Systems

Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease

Sotirios Tsimikas

AMERICAN JOURNAL OF CARDIOLOGY (2006)

Article Urology & Nephrology

ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease

K. Caglar et al.

KIDNEY INTERNATIONAL (2006)

Article Anesthesiology

From normal to pathological hemostasis

Dominique Lasne et al.

CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2006)

Article Biochemistry & Molecular Biology

Proposed structural models of the prothrombinase (FXa-FVa) complex

L Autin et al.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)

Article Hematology

Developmental haemostasis - Impact for clinical haemostasis laboratories

P Monagle et al.

THROMBOSIS AND HAEMOSTASIS (2006)

Article Obstetrics & Gynecology

The relationship of the factor v Leiden mutation and pregnancy outcomes for mother and fetus

D Dizon-Townson et al.

OBSTETRICS AND GYNECOLOGY (2005)

Article Biochemistry & Molecular Biology

Incorporation of factor Va into prothrombinase is required for coordinated cleavage of prothrombin by factor Xa

MA Bukys et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Hematology

The activity of the von Willebrand factor cleaving protease ADAMTS-13 in newborn infants

M Schmugge et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)

Review Biochemistry & Molecular Biology

The hemostatic system

JM Stassen et al.

CURRENT MEDICINAL CHEMISTRY (2004)

Article Multidisciplinary Sciences

The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function

TE Adams et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Review Hematology

Role of tissue factor in hemostasis, thrombosis, and vascular development

N Mackman

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)

Article Biochemistry & Molecular Biology

Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase

PV Jenkins et al.

BIOCHEMISTRY (2004)

Review Cardiac & Cardiovascular Systems

New markers of inflammation and endothelial cell activation - Part I

PE Szmitko et al.

CIRCULATION (2003)

Article Multidisciplinary Sciences

Endothelial cell diversity revealed by global expression profiling

JT Chi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Cardiac & Cardiovascular Systems

Endothelial dysfunction induced by hyperhomocyst(e)inemia -: Role of asymmetric dimethylarginine

MC Stühlinger et al.

CIRCULATION (2003)

Article Hematology

Thrombin and vascular development - A sticky subject

M Moser et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)

Review Medicine, General & Internal

Haemophilias A and B

PHB Bolton-Maggs et al.

LANCET (2003)

Review Cardiac & Cardiovascular Systems

Coming of age of C-reactive protein - Using inflammation markers in cardiology

ETH Yeh et al.

CIRCULATION (2003)

Article Hematology

Rare coagulation deficiencies

F Peyvandi et al.

HAEMOPHILIA (2002)

Review Hematology

Factor v and thrombotic disease -: Description of a janus-faced protein

GAF Nicolaes et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)

Article Cardiac & Cardiovascular Systems

Fundamentals of endothelial function for the clinical cardiologist

S Verma et al.

CIRCULATION (2002)

Review Hematology

A cell-based model of hemostasis

M Hoffman et al.

THROMBOSIS AND HAEMOSTASIS (2001)

Article Obstetrics & Gynecology

Performing and interpreting the bleeding time in the neonatal intensive care unit

A Del Vecchio et al.

CLINICS IN PERINATOLOGY (2000)

Article Medicine, General & Internal

Blood coagulation

B Dahlback

LANCET (2000)